Why Is Coinbase Stock Going Down?
Every way you look at it, Coinbase has had a…
Buy
78
ELMD Quote, Financials, Valuation and Earnings
Last price:
$29.23
Seasonality move
:
18.71%
Day range:
$28.80 - $29.99
52-week range:
$9.81 - $31.31
Dividend yield:
0%
P/E ratio:
40.61x
P/S ratio:
4.57x
P/B ratio:
5.96x
Volume:
56.1K
Avg. volume:
106.4K
1-year change:
183.88%
Market cap:
$247.3M
Revenue:
$54.7M
EPS (TTM):
$0.72
Analysts' Opinion
-
Consensus RatingElectromed has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Electromed has an estimated upside of 12.86% from its current price of $29.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $29.24.
Fair Value
-
According to the consensus of 0 analysts, Electromed has 12.86% upside to fair value with a price target of -- per share.
ELMD vs. S&P 500
-
Over the past 5 trading days, Electromed has overperformed the S&P 500 by 5.69% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Electromed does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Electromed has grown year-over-year revenues for 16 quarters straight. In the most recent quarter Electromed reported revenues of $14.7M.
Earnings Growth
-
Electromed has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Electromed reported earnings per share of $0.16.
Enterprise value:
233.4M
EV / Invested capital:
5.63x
Price / LTM sales:
4.57x
EV / EBIT:
27.87x
EV / Revenue:
4.09x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
20.66x
Price / Operating cash flow:
23.07x
Enterprise value / EBITDA:
25.31x
Gross Profit (TTM):
$43.7M
Return On Assets:
13.42%
Net Income Margin (TTM):
11.34%
Return On Equity:
15.62%
Return On Invested Capital:
15.62%
Operating Margin:
13.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $42.3M | $49.7M | $57.1M | $12.3M | $14.7M | |
| Gross Profit | $32.1M | $37.7M | $43.7M | $9.5M | $11.5M | |
| Operating Income | $2.5M | $4.1M | $8.4M | $142K | $1.9M | |
| EBITDA | $3.1M | $4.8M | $9.2M | $356K | $2.2M | |
| Diluted EPS | $0.22 | $0.37 | $0.72 | $0.02 | $0.16 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.3M | $32.4M | $33.2M | $36.2M | $41M | |
| Total Assets | $34.4M | $37.9M | $40.1M | $44.1M | $48.9M | |
| Current Liabilities | $3.5M | $4.8M | $6M | $5.8M | $7.4M | |
| Total Liabilities | $3.5M | $4.9M | $6M | $5.8M | $7.4M | |
| Total Equity | $30.9M | $33M | $34.1M | $38.2M | $41.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.8M | $2.8M | $11.6M | -$244K | $2.3M | |
| Cash From Investing | -$1.5M | -$1.6M | -$320K | -$133K | -$58K | |
| Cash From Financing | -$1.7M | -$146K | -$4.5M | $29K | -$4.5M | |
| Free Cash Flow | -$3.3M | $1.2M | $11.3M | -$377K | $2.3M | |
ELMD
Sector
Market Cap
$247.3M
$45.9M
Price % of 52-Week High
93.39%
46.95%
Dividend Yield
0%
0%
Shareholder Yield
2.65%
-0.6%
1-Year Price Total Return
183.88%
-32.15%
Beta (5-Year)
0.285
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$28.45
200-day SMA
Buy
Level
$19.09
Bollinger Bands (100)
Buy
Level
17.31 - 27.77
Chaikin Money Flow
Buy
Level
3.5M
20-day SMA
Buy
Level
$28.90
Relative Strength Index (RSI14)
Buy
Level
56.13
ADX Line
Buy
Level
10.05
Williams %R
Neutral
Level
-26.3093
50-day SMA
Buy
Level
$26.94
MACD (12, 26)
Buy
Level
0.44
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
19.1M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.067)
Buy
CA Score
(Annual)
Level (2.133)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-3.5688)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Stock Forecast FAQ
In the current month, ELMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ELMD average analyst price target in the past 3 months is --.
-
Where Will Electromed Stock Be In 1 Year?
According to analysts, the consensus estimate is that Electromed share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Electromed?
Analysts are divided on their view about Electromed share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Electromed is a Sell and believe this share price will drop from its current level to --.
-
What Is Electromed's Price Target?
The price target for Electromed over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ELMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Electromed is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ELMD?
You can purchase shares of Electromed via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Electromed shares.
-
What Is The Electromed Share Price Today?
Electromed was last trading at $29.23 per share. This represents the most recent stock quote for Electromed. Yesterday, Electromed closed at $29.24 per share.
-
How To Buy Electromed Stock Online?
In order to purchase Electromed stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
